| 1 | Connective tissue disease | Enrichment | COL2A1, FGFR3, NKX3-2, SOX9 | 4.86 |
| 2 | Metaphyseal anadysplasia | Enrichment | MMP13, MMP9 | 4.67 |
| 3 | Brachydactyly, type e1 | Enrichment | PTH1R, PTHLH | 4.20 |
| 4 | Silver-russell syndrome due to a point mutation | Enrichment | CDKN1C, IGF2 | 3.90 |
| 5 | Insulin-like growth factor i | Enrichment | IGF1, IGF1R | 3.68 |
| 6 | Colorectal cancer | Enrichment | AKT1, FGFR3, IGF2, SOX9 | 3.15 |
| 7 | Marfan syndrome | Enrichment | COL2A1, TGFB2 | 3.03 |
| 8 | Polydactyly, postaxial, type a1 | Enrichment | GLI3, PTCH1 | 2.67 |
| 9 | Gliosarcoma | Enrichment | FGFR1, FGFR3 | 2.61 |
| 10 | Microform holoprosencephaly | Enrichment | FGFR1, PTCH1 | 2.61 |
| 11 | Lobar holoprosencephaly | Enrichment | FGFR1, PTCH1 | 2.61 |
| 12 | Giant cell glioblastoma | Enrichment | FGFR1, FGFR3 | 2.56 |
| 13 | Beckwith-wiedemann syndrome | Enrichment | CDKN1C, IGF2 | 2.51 |
| 14 | Semilobar holoprosencephaly | Enrichment | FGFR1, PTCH1 | 2.51 |
| 15 | Craniosynostosis | Enrichment | FGFR3, GLI3 | 2.42 |
| 16 | Stickler syndrome, type i | Enrichment | COL2A1 | 2.33 |
| 17 | Pallister-hall syndrome | Enrichment | GLI3 | 2.33 |
| 18 | Short stature and advanced bone age with or without early-onset osteoarthritis and/or osteochondritis dissecans | Enrichment | ACAN | 2.33 |
| 19 | Hypochondroplasia | Enrichment | FGFR3 | 2.33 |
| 20 | Proteus syndrome | Enrichment | AKT1 | 2.33 |
| 21 | Osteoglophonic dysplasia | Enrichment | FGFR1 | 2.33 |
| 22 | Greig cephalopolysyndactyly syndrome | Enrichment | GLI3 | 2.33 |
| 23 | Epiphyseal dysplasia, multiple, with myopia and conductive deafness | Enrichment | COL2A1 | 2.33 |
| 24 | Thanatophoric dysplasia, type i | Enrichment | FGFR3 | 2.33 |
| 25 | Trigonocephaly 1 | Enrichment | FGFR1 | 2.33 |
| 26 | Spondylometaphyseal dysplasia, algerian type | Enrichment | COL2A1 | 2.33 |
| 27 | Muenke syndrome | Enrichment | FGFR3 | 2.33 |
| 28 | Osteoarthritis with mild chondrodysplasia | Enrichment | COL2A1 | 2.33 |
| 29 | Avascular necrosis of femoral head, primary, 1 | Enrichment | COL2A1 | 2.33 |
| 30 | Czech dysplasia | Enrichment | COL2A1 | 2.33 |
| 31 | Schilbach-rott syndrome | Enrichment | PTCH1 | 2.33 |
| 32 | Polydactyly, preaxial iv | Enrichment | GLI3 | 2.33 |
| 33 | Polyposis syndrome, hereditary mixed, 2 | Enrichment | BMPR1A | 2.33 |
| 34 | Hypophosphatasia, adult | Enrichment | ALPL | 2.33 |
| 35 | Kniest dysplasia | Enrichment | COL2A1 | 2.33 |
| 36 | Platyspondylic lethal skeletal dysplasia, torrance type | Enrichment | COL2A1 | 2.33 |
| 37 | Hypophosphatasia, childhood | Enrichment | ALPL | 2.33 |
| 38 | Keutel syndrome | Enrichment | MGP | 2.33 |
| 39 | Lamb-shaffer syndrome | Enrichment | SOX5 | 2.33 |
| 40 | Thanatophoric dysplasia, type ii | Enrichment | FGFR3 | 2.33 |
| 41 | Spondyloepiphyseal dysplasia, stanescu type | Enrichment | COL2A1 | 2.33 |
| 42 | Osteogenesis imperfecta, type x | Enrichment | SERPINH1 | 2.33 |
| 43 | Camptodactyly, tall stature, and hearing loss syndrome | Enrichment | FGFR3 | 2.33 |
| 44 | Achondrogenesis, type ii | Enrichment | COL2A1 | 2.33 |
| 45 | Arterial calcification, generalized, of infancy, 1 | Enrichment | ENPP1 | 2.33 |
| 46 | Growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant | Enrichment | STAT5B | 2.33 |
| 47 | 46,xy sex reversal 10 | Enrichment | SOX9 | 2.33 |
| 48 | Chromosome 2q37 deletion syndrome | Enrichment | HDAC4 | 2.33 |
| 49 | Tolchin-le caignec syndrome | Enrichment | SOX6 | 2.33 |
| 50 | 46,xx sex reversal 2 | Enrichment | SOX9 | 2.33 |
| 51 | Spondyloperipheral dysplasia | Enrichment | COL2A1 | 2.33 |
| 52 | Laron syndrome | Enrichment | GHR | 2.33 |
| 53 | Spondylometaepiphyseal dysplasia, short limb-hand type | Enrichment | DDR2 | 2.33 |
| 54 | Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language | Enrichment | MEF2C | 2.33 |
| 55 | Growth hormone insensitivity, partial | Enrichment | GHR | 2.33 |
| 56 | Spondyloepimetaphyseal dysplasia, aggrecan type | Enrichment | ACAN | 2.33 |
| 57 | Microvascular complications of diabetes 1 | Enrichment | VEGFA | 2.33 |
| 58 | Crouzon syndrome with acanthosis nigricans | Enrichment | FGFR3 | 2.33 |
| 59 | Camurati-engelmann disease 2 | Enrichment | TGFB2 | 2.33 |
| 60 | Ossification of the posterior longitudinal ligament of spine | Enrichment | ENPP1 | 2.33 |
| 61 | Acrocapitofemoral dysplasia | Enrichment | IHH | 2.33 |
| 62 | Spondyloepiphyseal dysplasia, kimberley type | Enrichment | ACAN | 2.33 |
| 63 | Osteochondrodysplasia, brachydactyly, and overlapping malformed digits | Enrichment | CHST11 | 2.33 |
| 64 | Stickler syndrome, type i, nonsyndromic ocular | Enrichment | COL2A1 | 2.33 |
| 65 | Iron overload | Enrichment | BMP6 | 2.33 |
| 66 | Hypophosphatemic rickets, autosomal recessive, 2 | Enrichment | ENPP1 | 2.33 |
| 67 | Immunodeficiency 31a | Enrichment | STAT1 | 2.33 |
| 68 | Cowden syndrome 6 | Enrichment | AKT1 | 2.33 |
| 69 | Cole disease | Enrichment | ENPP1 | 2.33 |
| 70 | Pigmented nodular adrenocortical disease, primary, 4 | Enrichment | PRKACA | 2.33 |
| 71 | Brachydactyly, type e2 | Enrichment | PTHLH | 2.33 |
| 72 | Immunodeficiency 31b | Enrichment | STAT1 | 2.33 |
| 73 | Spondylo-megaepiphyseal-metaphyseal dysplasia | Enrichment | NKX3-2 | 2.33 |
| 74 | Achondroplasia, severe, with developmental delay and acanthosis nigricans | Enrichment | FGFR3 | 2.33 |
| 75 | Hartsfield syndrome | Enrichment | FGFR1 | 2.33 |
| 76 | Cardioacrofacial dysplasia 1 | Enrichment | PRKACA | 2.33 |
| 77 | Prenatal benign hypophosphatasia | Enrichment | ALPL | 2.33 |
| 78 | Neurodevelopmental disorder with central hypotonia and dysmorphic facies | Enrichment | HDAC4 | 2.33 |
| 79 | Warburg-cinotti syndrome | Enrichment | DDR2 | 2.33 |
| 80 | Vitreoretinopathy with phalangeal epiphyseal dysplasia | Enrichment | COL2A1 | 2.33 |
| 81 | Lacrimoauriculodentodigital syndrome 2 | Enrichment | FGFR3 | 2.33 |
| 82 | Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha | Enrichment | THRA | 2.33 |
| 83 | 5q14.3 microdeletion syndrome | Enrichment | MEF2C | 2.33 |
| 84 | Autosomal dominant rhegmatogenous retinal detachment | Enrichment | COL2A1 | 2.33 |
| 85 | Turner syndrome | Enrichment | PTCH1 | 2.33 |
| 86 | Multiple epiphyseal dysplasia with myopia and deafness | Enrichment | COL2A1 | 2.33 |
| 87 | Complete atrioventricular septal defect without ventricular hypoplasia | Enrichment | MEF2C | 2.33 |
| 88 | Hypochondrogenesis | Enrichment | COL2A1 | 2.33 |
| 89 | Fgfr3-related chondrodysplasia | Enrichment | FGFR3 | 2.33 |
| 90 | Osteochondritis dissecans | Enrichment | ACAN | 2.33 |
| 91 | Camptodactyly-tall stature-scoliosis-hearing loss syndrome | Enrichment | FGFR3 | 2.33 |
| 92 | Dysspondyloenchondromatosis | Enrichment | COL2A1 | 2.33 |
| 93 | Monosomy 9q22.3 | Enrichment | PTCH1 | 2.33 |
| 94 | Hypopigmentation-punctate palmoplantar keratoderma syndrome | Enrichment | ENPP1 | 2.33 |
| 95 | Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome | Enrichment | CDKN1C | 2.33 |
| 96 | Lethal hydranencephaly-diaphragmatic hernia syndrome | Enrichment | PLAT | 2.33 |
| 97 | Mef2c-related disorder | Enrichment | MEF2C | 2.33 |
| 98 | Type 2 collagen-related bone disorder | Enrichment | COL2A1 | 2.33 |
| 99 | Hartsfield-bixler-demyer syndrome | Enrichment | FGFR1 | 2.33 |
| 100 | Short stature-advanced bone age-early-onset osteoarthritis syndrome | Enrichment | ACAN | 2.33 |
| 101 | Hirschsprung disease 1 | Enrichment | GLI3, IHH | 2.10 |
| 102 | Failure of tooth eruption, primary | Enrichment | PTH1R | 2.03 |
| 103 | Hypoparathyroidism, familial isolated, 1 | Enrichment | PTH | 2.03 |
| 104 | Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly | Enrichment | RUNX2 | 2.03 |
| 105 | Sorsby fundus dystrophy | Enrichment | TIMP3 | 2.03 |
| 106 | Metaphyseal chondrodysplasia, schmid type | Enrichment | COL10A1 | 2.03 |
| 107 | Campomelic dysplasia | Enrichment | SOX9 | 2.03 |
| 108 | Camurati-engelmann disease 1 | Enrichment | TGFB1 | 2.03 |
| 109 | Metaphyseal chondrodysplasia, jansen type | Enrichment | PTH1R | 2.03 |
| 110 | Spondyloepimetaphyseal dysplasia, strudwick type | Enrichment | COL2A1 | 2.03 |
| 111 | Spondylometaphyseal dysplasia, corner fracture type | Enrichment | COL2A1 | 2.03 |
| 112 | Metaphyseal dysplasia, spahr type | Enrichment | MMP13 | 2.03 |
| 113 | Chondrodysplasia, blomstrand type | Enrichment | PTH1R | 2.03 |
| 114 | Otospondylomegaepiphyseal dysplasia, autosomal recessive | Enrichment | COL2A1 | 2.03 |
| 115 | Growth hormone insensitivity syndrome with immune dysregulation 1, autosomal recessive | Enrichment | STAT5B | 2.03 |
| 116 | Spondyloepimetaphyseal dysplasia, missouri type | Enrichment | MMP13 | 2.03 |
| 117 | Quebec platelet disorder | Enrichment | PLAU | 2.03 |
| 118 | Cervical cancer | Enrichment | FGFR3 | 2.03 |
| 119 | Eiken syndrome | Enrichment | PTH1R | 2.03 |
| 120 | Legg-calve-perthes disease | Enrichment | COL2A1 | 2.03 |
| 121 | Ventricular tachycardia, catecholaminergic polymorphic, 4 | Enrichment | CALM1 | 2.03 |
| 122 | Keratosis, seborrheic | Enrichment | FGFR3 | 2.03 |
| 123 | Pfeiffer syndrome | Enrichment | FGFR1 | 2.03 |
| 124 | Jackson-weiss syndrome | Enrichment | FGFR1 | 2.03 |
| 125 | Encephalocraniocutaneous lipomatosis | Enrichment | FGFR1 | 2.03 |
| 126 | Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies | Enrichment | CDKN1C | 2.03 |
| 127 | Silver-russell syndrome 3 | Enrichment | IGF2 | 2.03 |
| 128 | Growth hormone deficiency, isolated partial | Enrichment | GHR | 2.03 |
| 129 | Otospondylomegaepiphyseal dysplasia, autosomal dominant | Enrichment | COL2A1 | 2.03 |
| 130 | Long qt syndrome 14 | Enrichment | CALM1 | 2.03 |
| 131 | Hypothyroidism, congenital, nongoitrous, 6 | Enrichment | THRA | 2.03 |
| 132 | Immunodeficiency 31c | Enrichment | STAT1 | 2.03 |
| 133 | Alpha-thalassemia/impaired intellectual development syndrome, x-linked | Enrichment | ALPL | 2.03 |
| 134 | Inflammatory bowel disease, immunodeficiency, and encephalopathy | Enrichment | TGFB1 | 2.03 |
| 135 | Kowarski syndrome | Enrichment | GH1 | 2.03 |
| 136 | Autosomal recessive hypophosphatemic rickets | Enrichment | ENPP1 | 2.03 |
| 137 | Tibial hemimelia | Enrichment | GLI3 | 2.03 |
| 138 | Rosette-forming glioneuronal tumor | Enrichment | FGFR1 | 2.03 |
| 139 | Synpolydactyly | Enrichment | GLI3 | 2.03 |
| 140 | Preterm premature rupture of the membranes | Enrichment | SERPINH1 | 2.03 |
| 141 | Pseudohypoparathyroidism | Enrichment | PTH1R | 2.03 |
| 142 | Camurati-engelmann disease | Enrichment | TGFB1 | 2.03 |
| 143 | Metaphyseal anadysplasia 2 | Enrichment | MMP9 | 2.03 |
| 144 | Fibrolamellar carcinoma | Enrichment | PRKACA | 2.03 |
| 145 | Loeys-dietz syndrome 4 | Enrichment | TGFB2 | 2.03 |
| 146 | Hypophosphatasia | Enrichment | ALPL | 2.03 |
| 147 | Familial avascular necrosis of the femoral head | Enrichment | COL2A1 | 2.03 |
| 148 | Cervix carcinoma | Enrichment | FGFR3 | 2.03 |
| 149 | Alpha thalassemia-x-linked intellectual disability syndrome | Enrichment | ALPL | 2.03 |
| 150 | Dystonia 28, childhood-onset | Enrichment | ENPP1 | 2.03 |
| 151 | Hereditary mixed polyposis syndrome | Enrichment | BMPR1A | 2.03 |
| 152 | Interfrontal craniofaciosynostosis | Enrichment | FGFR1 | 2.03 |
| 153 | Short stature due to growth hormone qualitative anomaly | Enrichment | GH1 | 2.03 |
| 154 | Postaxial polydactyly type b | Enrichment | GLI3 | 2.03 |
| 155 | Arterial calcification of infancy | Enrichment | ENPP1 | 2.03 |
| 156 | Growth delay due to insulin-like growth factor type 1 deficiency | Enrichment | IGF1 | 2.03 |
| 157 | Juvenile polyposis of infancy | Enrichment | BMPR1A | 2.03 |
| 158 | Silver-russell syndrome due to an imprinting defect of 11p15 | Enrichment | IGF2 | 2.03 |
| 159 | Laron syndrome with immunodeficiency | Enrichment | STAT5B | 2.03 |
| 160 | Campomelic dysplasia and related disorders | Enrichment | SOX9 | 2.03 |
| 161 | Silver-russell syndrome due to 11p15 microduplication | Enrichment | IGF2 | 2.03 |
| 162 | Ovarian cancer | Enrichment | AKT1, BMPR1A, PTCH1 | 1.94 |
| 163 | Brachydactyly, type a1 | Enrichment | IHH | 1.86 |
| 164 | Cleidocranial dysplasia 1 | Enrichment | RUNX2 | 1.86 |
| 165 | Crouzon syndrome | Enrichment | FGFR3 | 1.86 |
| 166 | Lacrimoauriculodentodigital syndrome 1 | Enrichment | FGFR3 | 1.86 |
| 167 | Achondroplasia | Enrichment | FGFR3 | 1.86 |
| 168 | Mccune-albright syndrome | Enrichment | COL2A1 | 1.86 |
| 169 | Hypogonadotropic hypogonadism 2 with or without anosmia | Enrichment | FGFR1 | 1.86 |
| 170 | Larsen syndrome | Enrichment | FGFR3 | 1.86 |
| 171 | Spondyloepiphyseal dysplasia congenita | Enrichment | COL2A1 | 1.86 |
| 172 | Juvenile polyposis syndrome | Enrichment | BMPR1A | 1.86 |
| 173 | Acrocallosal syndrome | Enrichment | GLI3 | 1.86 |
| 174 | Hypophosphatasia, infantile | Enrichment | ALPL | 1.86 |
| 175 | Aarskog-scott syndrome | Enrichment | GLI3 | 1.86 |
| 176 | 46,xx sex reversal 1 | Enrichment | SOX9 | 1.86 |
| 177 | Holoprosencephaly 7 | Enrichment | PTCH1 | 1.86 |
| 178 | Chromosome 8p11 myeloproliferative syndrome | Enrichment | FGFR1 | 1.86 |
| 179 | Umbilical hernia | Enrichment | GLI3 | 1.86 |
| 180 | Familial isolated hypoparathyroidism | Enrichment | PTH | 1.86 |
| 181 | Isolated growth hormone deficiency, type ib | Enrichment | GH1 | 1.86 |
| 182 | Hamartoma | Enrichment | FGFR3 | 1.86 |
| 183 | Testicular germ cell cancer | Enrichment | FGFR3 | 1.86 |
| 184 | Cleidocranial dysplasia | Enrichment | RUNX2 | 1.86 |
| 185 | Spermatocytoma | Enrichment | FGFR3 | 1.86 |
| 186 | Growth delay due to insulin-like growth factor i resistance | Enrichment | IGF1R | 1.86 |
| 187 | Multiple epiphyseal dysplasia | Enrichment | COL2A1 | 1.86 |
| 188 | Testicular cancer | Enrichment | FGFR3 | 1.86 |
| 189 | Beckwith-wiedemann syndrome due to imprinting defect of 11p15 | Enrichment | IGF2 | 1.86 |
| 190 | Isolated growth hormone deficiency, type ii | Enrichment | GH1 | 1.73 |
| 191 | Polydactyly, preaxial ii | Enrichment | PTCH1 | 1.73 |
| 192 | Saethre-chotzen syndrome | Enrichment | FGFR3 | 1.73 |
| 193 | Non-syndromic bicoronal craniosynostosis | Enrichment | FGFR3 | 1.73 |
| 194 | Pediatric systemic lupus erythematosus | Enrichment | SPP1 | 1.73 |
| 195 | Primary hyperparathyroidism | Enrichment | PTH | 1.73 |
| 196 | Hemifacial hyperplasia | Enrichment | FGFR3 | 1.64 |
| 197 | Enchondromatosis, multiple, ollier type | Enrichment | PTH1R | 1.64 |
| 198 | Alzheimer disease 2 | Enrichment | PLAU | 1.64 |
| 199 | Retinal detachment | Enrichment | COL2A1 | 1.64 |
| 200 | Congenital myopathy 3 with rigid spine | Enrichment | HMGCS1 | 1.64 |
| 201 | Ventricular septal defect 1 | Enrichment | BMP7 | 1.64 |
| 202 | Congenital heart defects, multiple types, 4 | Enrichment | BMP7 | 1.64 |
| 203 | Holoprosencephaly | Enrichment | FGFR1 | 1.64 |
| 204 | Nonsyndromic 46,xx testicular disorders/differences of sex development | Enrichment | SOX9 | 1.64 |
| 205 | Primary hypereosinophilic syndrome | Enrichment | FGFR1 | 1.64 |
| 206 | Generalized juvenile polyposis/juvenile polyposis coli | Enrichment | BMPR1A | 1.64 |
| 207 | Atrial septal defect 1 | Enrichment | TGFB2 | 1.56 |
| 208 | Spondyloepiphyseal dysplasia with congenital joint dislocations | Enrichment | ACAN | 1.56 |
| 209 | Developmental dysplasia of the hip 1 | Enrichment | COL2A1 | 1.56 |
| 210 | Basal cell nevus syndrome 1 | Enrichment | PTCH1 | 1.56 |
| 211 | Hemihyperplasia, isolated | Enrichment | IGF2 | 1.56 |
| 212 | Pierre robin syndrome | Enrichment | SOX9 | 1.56 |
| 213 | Holoprosencephaly 1 | Enrichment | FGFR1 | 1.56 |
| 214 | Testicular germ cell tumor | Enrichment | FGFR3 | 1.56 |
| 215 | Pseudoxanthoma elasticum | Enrichment | ENPP1 | 1.56 |
| 216 | Inflammatory bowel disease 25, autosomal recessive | Enrichment | TGFB1 | 1.56 |
| 217 | Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy | Enrichment | CALM1 | 1.56 |
| 218 | Basal cell carcinoma 1 | Enrichment | PTCH1 | 1.56 |
| 219 | Chronic mucocutaneous candidiasis | Enrichment | STAT1 | 1.56 |
| 220 | Il10-related early-onset inflammatory bowel disease | Enrichment | TGFB1 | 1.56 |
| 221 | Breast adenocarcinoma | Enrichment | AKT1 | 1.56 |
| 222 | Lung squamous cell carcinoma | Enrichment | FGFR3 | 1.56 |
| 223 | 46,xy disorder of sex development | Enrichment | FGFR3 | 1.56 |
| 224 | Myeloma, multiple | Enrichment | FGFR3, HDAC4 | 1.56 |
| 225 | Primary ovarian insufficiency | Enrichment | ADAMTS1, BMP6 | 1.51 |
| 226 | Nevus, epidermal | Enrichment | FGFR3 | 1.49 |
| 227 | Silver-russell syndrome 1 | Enrichment | IGF2 | 1.49 |
| 228 | Multiple enchondromatosis, maffucci type | Enrichment | COL2A1 | 1.49 |
| 229 | Pilomyxoid astrocytoma | Enrichment | FGFR1 | 1.49 |
| 230 | Congenital hydrocephalus | Enrichment | PTCH1 | 1.49 |
| 231 | Overgrowth syndrome | Enrichment | PTCH1 | 1.49 |
| 232 | Hypophosphatemic rickets | Enrichment | ENPP1 | 1.49 |
| 233 | Melanocytic nevus syndrome, congenital | Enrichment | SOX5 | 1.44 |
| 234 | Hemochromatosis, type 1 | Enrichment | BMP6 | 1.44 |
| 235 | Isolated growth hormone deficiency, type ia | Enrichment | GH1 | 1.44 |
| 236 | Catecholaminergic polymorphic ventricular tachycardia 1 | Enrichment | CALM1 | 1.44 |
| 237 | Catecholaminergic polymorphic ventricular tachycardia | Enrichment | CALM1 | 1.44 |
| 238 | Ellis-van creveld syndrome | Enrichment | PRKACA | 1.39 |
| 239 | Loeys-dietz syndrome | Enrichment | TGFB2 | 1.39 |
| 240 | Hypogonadotropic hypogonadism | Enrichment | FGFR1 | 1.39 |
| 241 | Cowden syndrome | Enrichment | AKT1 | 1.39 |
| 242 | Stickler syndrome | Enrichment | COL2A1 | 1.34 |
| 243 | Primary bone dysplasia | Enrichment | FGFR3 | 1.34 |
| 244 | 46,xy complete gonadal dysgenesis | Enrichment | SOX9 | 1.30 |
| 245 | Osteochondrodysplasia | Enrichment | FGFR3 | 1.30 |
| 246 | Familial colorectal cancer type x | Enrichment | BMPR1A | 1.30 |
| 247 | Specific learning disability | Enrichment | GHR | 1.30 |
| 248 | Septooptic dysplasia | Enrichment | FGFR1 | 1.26 |
| 249 | Renal hypodysplasia/aplasia 3 | Enrichment | FGFR3 | 1.26 |
| 250 | Meningioma | Enrichment | AKT1 | 1.26 |
| 251 | Diaphragmatic hernia, congenital | Enrichment | GLI3 | 1.23 |
| 252 | Hypercholesterolemia, familial, 1 | Enrichment | GHR | 1.23 |
| 253 | Acute promyelocytic leukemia | Enrichment | STAT5B | 1.23 |
| 254 | Nk-cell enteropathy | Enrichment | IGF1R | 1.23 |
| 255 | Hypogonadotropic hypogonadism 7 with or without anosmia | Enrichment | FGFR1 | 1.20 |
| 256 | Medulloblastoma | Enrichment | PTCH1 | 1.20 |
| 257 | 46,xy partial gonadal dysgenesis | Enrichment | SOX9 | 1.20 |
| 258 | Wilms tumor 1 | Enrichment | IGF2 | 1.17 |
| 259 | Osteogenesis imperfecta, type iii | Enrichment | SERPINH1 | 1.17 |
| 260 | Myopia | Enrichment | COL2A1 | 1.17 |
| 261 | Familial hypercholesterolemia | Enrichment | GHR | 1.17 |
| 262 | Septopreoptic holoprosencephaly | Enrichment | PTCH1 | 1.17 |
| 263 | Midline interhemispheric variant of holoprosencephaly | Enrichment | PTCH1 | 1.17 |
| 264 | Rhabdomyosarcoma | Enrichment | PTCH1 | 1.14 |
| 265 | Alzheimer disease, familial, 1 | Enrichment | PLAU | 1.12 |
| 266 | Alobar holoprosencephaly | Enrichment | PTCH1 | 1.12 |
| 267 | Heart, malformation of | Enrichment | COL2A1 | 1.09 |
| 268 | Normosmic congenital hypogonadotropic hypogonadism | Enrichment | FGFR1 | 1.09 |
| 269 | Arteriovenous malformations of the brain | Enrichment | TIMP3 | 1.07 |
| 270 | Ehlers-danlos syndrome | Enrichment | TGFB2 | 1.07 |
| 271 | Williams-beuren syndrome | Enrichment | CDKN1C | 1.05 |
| 272 | Macs syndrome | Enrichment | PTCH1 | 1.05 |
| 273 | Hepatoblastoma | Enrichment | FGFR3 | 1.03 |
| 274 | Microphthalmia | Enrichment | PTCH1 | 1.01 |
| 275 | Tooth agenesis | Enrichment | FGFR1 | 1.01 |
| 276 | Brittle bone disorder | Enrichment | ALPL | 0.99 |
| 277 | Kallmann syndrome | Enrichment | FGFR1 | 0.99 |
| 278 | Scoliosis | Enrichment | COL2A1 | 0.98 |
| 279 | Strabismus | Enrichment | SOX5 | 0.93 |
| 280 | Inherited cancer-predisposing syndrome | Enrichment | BMPR1A, PTCH1 | 0.90 |
| 281 | Bladder cancer | Enrichment | FGFR3 | 0.90 |
| 282 | Long qt syndrome 1 | Enrichment | CALM1 | 0.88 |
| 283 | Stargardt disease 1 | Enrichment | COL2A1 | 0.88 |
| 284 | Long qt syndrome | Enrichment | CALM1 | 0.87 |
| 285 | Cystic fibrosis | Enrichment | TGFB1 | 0.86 |
| 286 | Systemic lupus erythematosus | Enrichment | SPP1 | 0.78 |
| 287 | Type 2 diabetes mellitus | Enrichment | ENPP1 | 0.75 |
| 288 | Nephrotic syndrome | Enrichment | RUNX2 | 0.74 |
| 289 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | TGFB2 | 0.73 |
| 290 | Hereditary breast carcinoma | Enrichment | AKT1 | 0.73 |
| 291 | Body mass index quantitative trait locus 11 | Enrichment | ENPP1 | 0.68 |
| 292 | Hereditary breast ovarian cancer syndrome | Enrichment | PTCH1 | 0.65 |
| 293 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | MEF2C | 0.63 |
| 294 | Breast cancer | Enrichment | AKT1 | 0.53 |
| 295 | Congenital nervous system abnormality | Enrichment | FGFR3 | 0.41 |
| 296 | Nervous system disease | Enrichment | FGFR3 | 0.41 |
| 297 | Hereditary retinal dystrophy | Enrichment | COL2A1, TIMP3 | 0.41 |
| 298 | Fundus dystrophy | Enrichment | COL2A1, TIMP3 | 0.41 |
| 299 | Autism spectrum disorder | Enrichment | MEF2C | 0.40 |
| 300 | Microcephaly | Enrichment | IGF1R | 0.36 |
| 301 | Retinitis pigmentosa | Enrichment | IFT88 | 0.20 |